cytarabine has been researched along with artesunic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Jia, YQ; Meng, WT; Ni, X; Wen, Q; Zeng, Y | 1 |
Baker, SD; Buaboonnam, J; Drenberg, CD; Fan, Y; Guy, RK; Hu, S; Li, L; Orwick, SJ; Rubnitz, J; Shelat, AA | 1 |
Gong, P; Jing, Y; Wang, Y; Waxman, S; Yin, C; Zhang, J; Zhang, Z; Zhao, L | 1 |
Chen, X; Gao, XH; Hao, HL; Huang, C; Li, J; Li, JY; Li, Y; Liu, JY; Tu, CQ; Wang, DW; Wang, RC; Xiong, X; Yang, J; Yang, YB; Yuan, J; Zhang, XX; Zhang, XY; Zheng, CF; Zou, LL | 1 |
Chen, Y; Huang, P; Li, H; Luo, X; Su, Q; Zhang, P | 1 |
5 other study(ies) available for cytarabine and artesunic acid
Article | Year |
---|---|
[Inhibitive effect of artesunate on human lymphoblastic leukemia/lymphoma cells].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Artesunate; Blood-Brain Barrier; Cell Line, Tumor; Cytarabine; Drug Synergism; Humans; Jurkat Cells; Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2009 |
Evaluation of artemisinins for the treatment of acute myeloid leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemisinins; Artesunate; Cell Line, Tumor; Cell Survival; Cytarabine; High-Throughput Screening Assays; Humans; Leukemia, Myeloid, Acute; Lysosomes; Mice, Inbred Strains; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2016 |
Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis.
Topics: Aged; Animals; Apoptosis; Apoptosis Regulatory Proteins; Artesunate; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Checkpoint Kinase 1; Cytarabine; Humans; Leukemia, Myeloid, Acute; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Sulfonamides | 2022 |
Topics: Apoptosis; Artesunate; Caspase 3; Caspase 9; Cell Line; Cytarabine; Daunorubicin; Humans; Leukemia; Leukemia, Myeloid, Acute; Mutation; Retrospective Studies | 2022 |
Artesunate reverses cytarabine resistance in acute myeloid leukemia by blocking the JAK/STAT3 signaling.
Topics: Artesunate; Cytarabine; Humans; Janus Kinases; Leukemia, Myeloid, Acute; Signal Transduction; STAT3 Transcription Factor | 2023 |